Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course
American Journal of Epidemiology · 05.05.2023 · 192 (5) · 703-713
DOI: 10.1093/aje/kwac164 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, online erschienen am 29.09.2022. Verfasst von Sylvia E K Sudat und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Drug Treatment, Dexamethasone, Health Equity. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Arterial blood oxygen saturation as measured by pulse oximetry (peripheral oxygen saturation (SpO2)) may be differentially less accurate for people with darker skin pigmentation, which could potentially affect the course of coronavirus disease 2019 (COVID-19) treatment. We analyzed pulse oximeter accuracy and its association with COVID-19 treatment outcomes using electronic health record data from Sutter Health, a large, mixed-payer, integrated health-care delivery system in Northern California. We analyzed 2 cohorts: 1) 43,753 non-Hispanic White (NHW) or non-Hispanic Black/African-American (NHB) adults with concurrent arterial blood gas oxygen saturation/SpO2 measurements taken between January 2020 and February 2021; and 2) 8,735 adults who went to a hospital emergency department with COVID-19 between July 2020 and February 2021. Pulse oximetry systematically overestimated blood oxygenation by 1% more in NHB individuals than in NHW individuals. For people with COVID-19, this was associated with lower admission probability (−3.1 percentage points), dexamethasone treatment (−3.1 percentage points), and supplemental oxygen treatment (−4.5 percentage points), as well as increased time to treatment: 37.2 minutes before dexamethasone initiation and 278.5 minutes before initiation of supplemental oxygen. These results call for additional investigation of pulse oximeters and suggest that current guidelines for development, testing, and calibration of these devices should be revisited, investigated, and revised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Sudat, S. E. K., Wesson, P., Rhoads, K. F., Brown, S., Aboelata, N., Pressman, A. R., Mani, A., & Azar, K. M. J. (2023). Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course. American Journal of Epidemiology, 192(5), 703-713. https://doi.org/10.1093/aje/kwac164
Vancouver
Sudat SEK, Wesson P, Rhoads KF, Brown S, Aboelata N, Pressman AR, et al. Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course. American Journal of Epidemiology. 2023;192(5):703-713. doi:10.1093/aje/kwac164
BibTeX
@article{Sudat2023,
author = {Sudat, Sylvia E K and Wesson, Paul and Rhoads, Kim F and Brown, Stephanie and Aboelata, Noha and Pressman, Alice R and Mani, Aravind and Azar, Kristen M J},
title = {Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course},
journal = {American Journal of Epidemiology},
year = {2023},
volume = {192},
number = {5},
pages = {703--713},
doi = {10.1093/aje/kwac164}
}
EUVIMED